Valuation: INVO Fertility, Inc.

Market Cap 1.74M 1.5M 1.41M 1.28M 2.41M 166M 2.44M 16.48M 6.46M 83.13M 6.52M 6.37M 277M P/E 2026 *
-0.04x
P/E 2027 * -0.12x
Enterprise Value 1.74M 1.5M 1.41M 1.28M 2.41M 166M 2.44M 16.48M 6.46M 83.13M 6.52M 6.37M 277M EV / Sales 2026 *
0.17x
EV / Sales 2027 * 0.11x
Free-Float
99.01%
Yield 2026 *
-
Yield 2027 * -
1 day+109.95%
1 week+96.14%
Current month+117.75%
1 month+96.14%
3 months+35.99%
6 months-60.00%
Current year-45.79%
1 week 0.95
Extreme 0.954
2.8
1 month 0.9
Extreme 0.9001
2.8
Current year 0.9
Extreme 0.9001
22.9
1 year 0.9
Extreme 0.9001
84.4
3 years 0.9
Extreme 0.9001
1,785.46
5 years 0.9
Extreme 0.9001
1,785.46
10 years 0.9
Extreme 0.9001
1,785.46
Date Insider Type Main position Quantity % Market Cap.
12/30/25 Other

Chief Financial Officer

4,399 0.2326%
12/3/25 Sell

Director

7 0.0004%
8/26/25 Other

Director

45,000 4.8477%
Change 5-day change 1-year change 3-year change Capi.($)
+106.36%+96.14%-96.38% - 1.74M
-0.83%+1.39%-15.46%+4.96% 193B
-0.13%+1.88%-1.85%+11.68% 117B
+0.81%-2.74%+8.87%+75.62% 59.89B
-0.92%+2.96%+36.26%+64.79% 56.01B
-0.25%+1.94%-6.09%-33.54% 49.96B
-1.40%+1.04%+9.58%-17.86% 33.87B
-1.87%+3.71% - - 31.36B
-1.96%+10.41%-4.73%+24.70% 24.77B
+0.32%-0.63%+43.95%-10.93% 24.59B
Average +10.36%+2.38%-2.87%+14.93% 58.98B
Weighted average by Cap. -0.59%+3.34%+0.63%+15.29%

Financials

2026 *2027 *
Net sales 10.42M 8.99M 8.44M 7.69M 14.45M 996M 14.65M 98.92M 38.76M 499M 39.12M 38.27M 1.66B 16.46M 14.21M 13.33M 12.14M 22.83M 1.57B 23.15M 156M 61.24M 789M 61.8M 60.46M 2.62B
Net income -5.44M -4.7M -4.41M -4.02M -7.55M -520M -7.65M -51.68M -20.25M -261M -20.44M -19.99M -867M -3.03M -2.61M -2.45M -2.23M -4.2M -289M -4.26M -28.73M -11.26M -145M -11.36M -11.11M -482M
Net Debt - -
Logo INVO Fertility, Inc.
INVO Fertility Inc. is a healthcare services fertility company, which is engaged in expanding access to assisted reproductive technology (ART) care to patients in need. The Company’s principal commercial strategy is focused on building, acquiring, and operating fertility clinics, including INVO Centers dedicated primarily to offering the intravaginal culture (IVC) procedure enabled by its INVOcell medical device (INVOcell) and United States-based, profitable in vitro fertilization (IVF) clinics. The Company has four operational fertility clinics in the United States. The Company is also engaged in the sale and distribution of INVOcell to third-party owned and operated fertility clinics. INVOcell is a proprietary medical device that allows fertilization and early embryo development to take place in vivo within the woman's body. The IVC procedure provides patients with a more connected, intimate, and affordable experience in comparison to other ART treatments.
Employees
-
Date Price Change Volume
26-08-17 US$2.040 +109.97% 97,790,308
26-08-14 US$0.9716 +0.15% 51,893
26-08-13 US$0.9701 -3.95% 41,804
26-08-12 US$1.010 -1.94% 62,028
26-08-11 US$1.030 -0.96% 38,651
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
0.9716USD
Average target price
20.00USD
Spread / Average Target
+1,958.46%

Quarterly revenue - Rate of surprise